During the past decade, Hôpital Nord Franche-Comté conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 2 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Nord Franche-Comté" #1 sponsor was "Centre Hospitalier Universitaire de Besancon" with 21 trials, followed by "Hopital Nord Franche-Comte" with 6 trials sponsored, "Groupe Francophone des Myelodysplasies" with 3 trials sponsored, "Nantes University Hospital" with 3 trials sponsored and "Central Hospital, Nancy, France" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Nord Franche-Comté" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Hopital Nord Franche-Comte" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Nord Franche-Comté" are "Metastatic Colorectal Cancer" (4 trials), "Metastatic Pancreatic Adenocarcinoma" (3 trials), "COVID-19" (2 trials), "Colorectal Cancer" (2 trials) and "Critical Care" (2 trials). Many other conditions were trialed in "Hôpital Nord Franche-Comté" in a lesser frequency.

Most popular intervention types in "Hôpital Nord Franche-Comté" are "Drug" (27 trials), "Other" (24 trials), "Device" (8 trials), "Procedure" (7 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (4 trials), "Placebo" (4 trials), "Additional biological samples" (3 trials), "Bevacizumab" (3 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Nord Franche-Comté" are 62 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Nord Franche-Comté". 2 are not yet recruiting, 21 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Hôpital Nord Franche-Comté, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Nord Franche-Comté, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 22 trials that are defined as “Not Applicable".